LobbyingSixteen Thirty Fund lobbying by quarter
Sixteen Thirty Fund's latest lobbying report covers Q3 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $933K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Sixteen Thirty Fund
- Latest quarter
- $40K
- Q3 2026 · 1 reports
- Last 12 months
- $933K
- Last 4 quarters
- vs last quarter
- −85.7%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $1.4M | 4 |
| Q1 2023 | $560K | 3 |
| Q2 2023 | $340K | 4 |
| Q3 2023 | $380K | 3 |
| Q4 2023 | $640K | 3 |
| Q1 2024 | $1.1M | 3 |
| Q2 2024 | $2M | 3 |
| Q3 2024 | $560K | 3 |
| Q4 2024 | $600K | 3 |
| Q1 2025 | $280K | 3 |
| Q2 2025 | $410K | 3 |
| Q3 2025 | $420K | 3 |
| Q4 2025 | $373K | 3 |
| Q1 2026 | $240K | 3 |
| Q2 2026 | $280K | 3 |
| Q3 2026 | $40K | 1 |
By issue
- Health issues$940K · 32 reports
- Medicare and Medicaid$300K · 16 reports
- Economic development$50K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES32 reports
- SENATE32 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSixteen Thirty Fund | $8.3M | 15 quarters |
| Pontifex Strategies | $640K | 16 quarters |
| Fontenot Health Policy | $490K | 13 quarters |
| Avenue Solutions | $110K | 3 quarters |
| Kountoupes Denham Carr & Reid | $50K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ELLEN DONESKI | Chief Tax and Economic Policy Advisor, Senator Harry Reid; Staff Director, Senate Commerce Committee, Senator Jay Rockefeller; Legislative Director, Senator Jay Rockefeller. | Q3 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/18for Q3 | Pontifex Strategies | $40K |
| 07/20for Q2 | In-house | $200K |
| 07/08for Q2 | Pontifex Strategies | $40K |
| 07/06for Q2 | Fontenot Health Policy | $40K |
| 04/20for Q1 | In-house | $160K |
| 04/10for Q1 | Fontenot Health Policy | $40K |
| 04/07for Q1 | Pontifex Strategies | $40K |
| 01/20for Q4 2025 | In-house | $293K |
| 01/13for Q4 2025 | Fontenot Health Policy | $40K |
| 25/12/29for Q4 2025 | Pontifex Strategies | $40K |
| 25/10/20for Q3 2025 | In-house | $340K |
| 25/10/10for Q3 2025 | Fontenot Health Policy | $40K |
| 25/10/06for Q3 2025 | Pontifex Strategies | $40K |
| 25/07/21for Q2 2025 | In-house | $330K |
| 25/07/16for Q2 2025 | Fontenot Health Policy | $40K |
| 25/07/02for Q2 2025 | Pontifex Strategies | $40K |
| 25/04/21for Q1 2025 | In-house | $200K |
| 25/04/17for Q1 2025 | Fontenot Health Policy | $40K |
| 25/04/14for Q1 2025 | Pontifex Strategies | $40K |
| 25/01/23for Q4 2024 | In-house | $520K |